Literature DB >> 9568700

Reversibility of retinal flow abnormalities is disease-duration dependent in diabetic rats.

S Higashi1, A C Clermont, V Dhir, S E Bursell.   

Abstract

Decreased retinal blood flow has been measured in streptozotocin (STZ)-induced diabetes of 1 week's duration, and primary insulin intervention was effective in maintaining normal retinal blood flow in diabetic rats. Retinal blood-flow abnormalities precede clinical diabetic retinopathy in both diabetic animals and patients. An important characteristic of diabetic retinopathy is the difficulty of reversibility once it has been established. Because altered retinal hemodynamics is a possible marker of early diabetic retinopathy, we investigated in this study whether retinal blood-flow changes in rats can be normalized by secondary insulin intervention following short and chronic periods of untreated STZ-induced diabetes. Subcutaneous insulin pumps were placed into diabetic rats for 1 week after 1 week of diabetes (2-week group) and after 3 weeks of diabetes (4-week group). Retinal circulatory parameters were determined using image analysis of video fluorescein angiogram recordings. For the 2-week group, retinal blood flow was significantly (P < 0.05) reduced in the untreated diabetic rats compared with nondiabetic and insulin-treated diabetic rats (80.6+/-29.2, 131.9+/-50.1, and 151.3+/-54.0 pixels2/s respectively). Retinal blood flow was also significantly (P < 0.05) reduced in the 4-week untreated diabetic rats compared with nondiabetic rats (95.7+/-22.2 vs. 125.7+/-29.5 pixels2/s). In contrast to the shorter-duration group, insulin treatment for 1 week after 3 weeks of diabetes did not totally normalize retinal blood flow (117.5+/-32.4 pixels2/s). These results suggest that vascular abnormalities could become more resistant to normalization following short-term (1 week) insulin treatment after longer periods of untreated diabetes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9568700     DOI: 10.2337/diabetes.47.4.653

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  10 in total

1.  Retinal expression, regulation, and functional bioactivity of prostacyclin-stimulating factor.

Authors:  Y Hata; A Clermont; T Yamauchi; E A Pierce; I Suzuma; H Kagokawa; H Yoshikawa; G S Robinson; T Ishibashi; T Hashimoto; F Umeda; S E Bursell; L P Aiello
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

2.  Attenuation of diabetes-induced retinal vasoconstriction by a thromboxane receptor antagonist.

Authors:  William S Wright; Jodine E Messina; Norman R Harris
Journal:  Exp Eye Res       Date:  2008-11-01       Impact factor: 3.467

3.  Effect of sulodexide on endothelial glycocalyx and vascular permeability in patients with type 2 diabetes mellitus.

Authors:  L N Broekhuizen; B A Lemkes; H L Mooij; M C Meuwese; H Verberne; F Holleman; R O Schlingemann; M Nieuwdorp; E S G Stroes; H Vink
Journal:  Diabetologia       Date:  2010-09-25       Impact factor: 10.122

Review 4.  Functional hyperemia and mechanisms of neurovascular coupling in the retinal vasculature.

Authors:  Eric A Newman
Journal:  J Cereb Blood Flow Metab       Date:  2013-08-21       Impact factor: 6.200

5.  Measurement of retinal blood flow rate in diabetic rats: disparity between techniques due to redistribution of flow.

Authors:  Wendy Leskova; Megan N Watts; Patsy R Carter; Randa S Eshaq; Norman R Harris
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-04-26       Impact factor: 4.799

Review 6.  Role of endothelial cell and pericyte dysfunction in diabetic retinopathy: review of techniques in rodent models.

Authors:  Jonathan Chou; Stuart Rollins; Amani A Fawzi
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

7.  Temporal development of retinal arteriolar endothelial dysfunction in porcine type 1 diabetes.

Authors:  Travis W Hein; Luke B Potts; Wenjuan Xu; Josh Z Yuen; Lih Kuo
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-12-03       Impact factor: 4.799

Review 8.  MRI biomarkers for evaluation of treatment efficacy in preclinical diabetic retinopathy.

Authors:  Bruce A Berkowitz; David Bissig; Oliver Dutczak; Shannon Corbett; Rob North; Robin Roberts
Journal:  Expert Opin Med Diagn       Date:  2013-06-21

9.  Increased intraretinal PO2 in short-term diabetic rats.

Authors:  Jennifer C M Lau; Robert A Linsenmeier
Journal:  Diabetes       Date:  2014-07-15       Impact factor: 9.461

10.  The 5-year onset and regression of diabetic retinopathy in Chinese type 2 diabetes patients.

Authors:  Peiyao Jin; Jinjuan Peng; Haidong Zou; Weiwei Wang; Jiong Fu; Binjie Shen; Xuelin Bai; Xun Xu; Xi Zhang
Journal:  PLoS One       Date:  2014-11-17       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.